Quanterix Corporation Goodwill, Translation and Purchase Accounting Adjustments
Quanterix Corporation (QTRX) reported Goodwill, Translation and Purchase Accounting Adjustments of -$828.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes
us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments · last filed 2022-03-01
- Quanterix Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2021-12-31 was -$271.00K, a 136.38% decline year-over-year.
- Quanterix Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2021-09-30 was -$218.00K, a 167.08% decline year-over-year.
- Quanterix Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2021-06-30 was $188.00K, a 60.50% decline year-over-year.
- Quanterix Corporation goodwill, translation and purchase accounting adjustments for the quarter ending 2021-03-31 was -$527.00K.
- Quanterix Corporation goodwill, translation and purchase accounting adjustments for fiscal 2021 was -$828.00K, a 174.80% decline from fiscal 2020.
- Quanterix Corporation goodwill, translation and purchase accounting adjustments for fiscal 2020 was $1.11M.
- Quanterix Corporation goodwill, translation and purchase accounting adjustments for fiscal 2019 was -$66.00K.
| Period end | Goodwill, Translation and Purchase Accounting Adjustments 3 month | Goodwill, Translation and Purchase Accounting Adjustments 6 month | Goodwill, Translation and Purchase Accounting Adjustments 9 month | Goodwill, Translation and Purchase Accounting Adjustments 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$489.00K derived: sum of 2 quarters · filed 2022-03-01 | -$301.00K derived: sum of 3 quarters · filed 2022-03-01 | -$828.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | -$218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$30.00K derived: sum of 2 quarters · filed 2021-11-04 | -$557.00K 10-Q · filed 2021-11-04 | $188.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | $188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$339.00K 10-Q · filed 2021-08-05 | $406.00K derived: sum of 3 quarters · filed 2021-08-05 | $731.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | -$527.00K 10-Q · filed 2021-05-06 | $218.00K derived: sum of 2 quarters · filed 2021-05-06 | $543.00K derived: sum of 3 quarters · filed 2021-05-06 | $1.02M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | $745.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $1.07M derived: sum of 2 quarters · filed 2021-03-05 | $1.55M derived: sum of 3 quarters · filed 2021-03-05 | $1.11M 10-K · filed 2021-03-05 |
| 2020-09-30 | $325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $801.00K derived: sum of 2 quarters · filed 2020-11-06 | $362.00K 10-Q · filed 2020-11-06 | $754.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | $476.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $37.00K 10-Q · filed 2020-08-04 | $429.00K derived: sum of 3 quarters · filed 2020-08-04 | |
| 2020-03-31 | -$439.00K 10-Q · filed 2020-05-07 | -$47.00K derived: sum of 2 quarters · filed 2020-05-07 | ||
| 2019-12-31 | $392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$66.00K 10-K · filed 2020-03-13 | ||
| 2019-09-30 | -$458.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |